CADILA HEALTHCARE COMPLETES ANIMAL HEALTHCARE SALE WORTH RS 2,921 CR

Highlights

• In a regulatory filing, Cadila Healthcare said "The transaction of sale and disposal is completed /closed today i.e. July 14, 2021.”

According to a statement issued by Cadila Healthcare on Thursday, its wholly-owned subsidiary Zydus Animal Health a...

ZYDUS CADILA GETS USFDA APPROVAL FOR POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS

Highlights

• Zydus Cadila, part of Cadila Healthcare group in a BSE filing said it has received final approval from the United States Food and Drug Administration (USFDA) in order to market Potassium Chloride extended release tablets in the strengths of 10 mEq (750 mg) and 20 mEq (...